ABT
$49.71
Abbott Laboratories
$.83
1.70%
ABT
Earnings Whisper ®
N/A
3rd Quarter September 2017
Consensus:  $0.65
Revenue:  $6.71 Bil
Thursday
Oct 19
7:45 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ABT reports earnings?
Beat
Meet
Miss

Where is ABT's stock price going from here?
Up
Flat
Down
Stock chart of ABT
Analysts
Summary of analysts' recommendations for ABT
Score
Grade
Pivots
Resistance
$51.05
$50.45
$50.08

$49.48

Support
$49.11
$48.51
$48.14
Tweet
Growth
Description
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Peers
StrykerBoston ScientificIntegra LifeSciences HoldingsBaxter InternationalBecton, DickinsonC. R. Bard3MResMedWatersHill-Rom Holdings